| 1 |
2024 |
Mirosława Püsküllüoğlu, Izabela Michalak. The therapeutic potential of natural metabolites in targeting endocrine-independent HER-2-negative breast cancer, Frontiers in Pharmacology. 2024; 15: 1349242.
https://doi.org/10.3389/fphar.2024.1349242 |
| 2 |
2023 |
Deguang Liang, Yan Feng, Fereshteh Zandkarimi, Hua Wang, Zeda Zhang, Jinnie Kim, Yanyan Cai, Wei Gu, Brent R. Stockwell, Xuejun Jiang. Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones, Cell. 2023; 186: 2748.
https://doi.org/10.1016/j.cell.2023.05.003 |
| 3 |
2023 |
Satyam Bhasin, Christopher Dusek, James W. Peacock, Artem Cherkasov, Yuzhuo Wang, Martin Gleave, Christopher J. Ong. Dependency of Tamoxifen Sensitive and Resistant ER+ Breast Cancer Cells on Semaphorin 3C (SEMA3C) for Growth, Cells. 2023; 12: 1715.
https://doi.org/10.3390/cells12131715 |
| 4 |
2024 |
Cigir Biray Avci, Bakiye Goker Bagca, Behrouz Shademan, Leila Sabour Takanlou, Maryam Sabour Takanlou, Alireza Nourazarian. The future of cancer therapy: exploring the potential of patient-derived organoids in drug development, Frontiers in Cell and Developmental Biology. 2024; 12: 1401504.
https://doi.org/10.3389/fcell.2024.1401504 |
